0 Σχόλια
0 Μοιράστηκε
783 Views
Προωθημένο
Αναζήτηση
Ανακάλυψε νέους ανθρώπους, δημιούργησε νέες συνδέσεις και κάνε καινούργιους φίλους
- Παρακαλούμε συνδέσου στην Κοινότητά μας για να δηλώσεις τι σου αρέσει, να σχολιάσεις και να μοιραστείς με τους φίλους σου!
- Precision Oncology Market Industry, & Share Analysis Report 2023-2030The Precision Oncology Market Industry was estimated to be worth USD 96.5 billion in 2022, with a projected growth to reach USD 200.9 billion by 2030. This represents a compound annual growth rate (CAGR) of 9.6% during the forecast period from 2023 to 2030. Precision oncology, a rapidly expanding field, focuses on tailoring cancer treatment to individual patients based on their...0 Σχόλια 0 Μοιράστηκε 613 Views
- Unveiling the Power of Verteporfin: A Beacon of Hope in Medical InnovationVerteporfin, a remarkable compound derived from porphyrin, has emerged as a beacon of hope in the realm of medical innovation. With its unique properties and versatile applications, Verteporfin is transforming the landscape of treatment options for various diseases and conditions. In the field of ophthalmology, Verteporfin has become synonymous with photodynamic therapy (PDT)...0 Σχόλια 0 Μοιράστηκε 584 Views
- "Revolutionizing Cancer Care: The AI in Oncology Market Landscape and Future Prospects"AI in Oncology Market is worth USD 0.76 billion in 2022 and is estimated to grow at a CAGR of 35.4% in the forecasted period. The forecasted revenue hints at a growth of around 6.4 billion USD by 2029. AI in Oncology Market Overview : The latest study from Maximize Market Research, AI in Oncology Market , is helpful in understanding the market's competitors. The study...0 Σχόλια 0 Μοιράστηκε 887 Views
- "Securing Market Leadership: Oncology Drugs Market Share Analysis and Strategies"Unveiling Insights into the Oncology Drugs Market: Size, Share, Analysis, Trends, and Outlook The Oncology Drugs Market stands at the forefront of the pharmaceutical industry, addressing the complex and evolving landscape of cancer treatment. Let's delve into the nuances of this market, exploring its size, share, analysis, trends, and outlook to gain a comprehensive understanding of its...0 Σχόλια 0 Μοιράστηκε 423 Views
- Advancements in AI Oncology Solutions (2023-2029)AI in Oncology Market is worth USD 0.76 billion in 2022 and is estimated to grow at a CAGR of 35.4% in the forecasted period. The forecasted revenue hints at a growth of around 6.4 billion USD by 2029. AI in Oncology Market Scope: The report goes over demand estimates, market trends, and micro and macro variables in great detail. This study also highlights the elements...0 Σχόλια 0 Μοιράστηκε 872 Views
- Advancing Precision Oncology: Exploring Biomarkers For PARP Inhibitor Therapy In Cancer TreatmentPrecision medicine aims to match the right treatment to the right patient based on the molecular characteristics of their cancer. PARP inhibitors are one type of targeted therapy that has shown promise in certain breast and ovarian cancers linked to defective DNA repair pathways. However, identifying predictive biomarkers remains an active area of research to optimize patient selection and...0 Σχόλια 0 Μοιράστηκε 587 Views
- AI in Oncology Market Analysis by Size, Growth, By Segmentation, By applicationAI in Oncology Market is expected to reach US$ 16.72 Bn. by 2029, at a CAGR of 11.5% during the forecast period. AI in Oncology Market Report Overview The AI in Oncology market report is a comprehensive analysis of the AI in Oncology Market, drawing on both primary and secondary research methods. It provides a detailed analysis of the global and regional market size and share, as...0 Σχόλια 0 Μοιράστηκε 815 Views
- AI's Global Impact on Omics Studies: Revolutionizing Science and HealthcareArtificial intelligence (AI) is disruptively transforming science and healthcare across the globe. One area that AI is making major strides is omics studies which include genomics, proteomics, transcriptomics and metabolomics. Through machine learning algorithms trained on massive omics datasets, AI is enabling new insights into human health and disease at an unprecedented scale and...0 Σχόλια 0 Μοιράστηκε 555 Views
- Biosimilars in Oncology: Enhancing Access to Cancer TreatmentsThe field of cell therapy is rapidly advancing, driven by innovations from key leaders such as Kolon TissueGene Inc., AlloSource, Holostem Terapie Avanzate S.R.L., and Anterogen Co. Ltd., among others. These organizations are pioneering advancements in regenerative medicine, particularly in autologous and allogeneic therapies, with significant implications for various therapeutic areas,...0 Σχόλια 0 Μοιράστηκε 110 Views
Αναζήτηση αποτελεσμάτων
Προωθημένο
© 2024 Humwaten pakistan Ist social website Greek